Abstract

Coccidioidomycosis is usually a self-limited infection, but chronic, life-threatening disease can develop, especially in immunocompromised individuals. Treatment options include amphotericin B and azole antifungals. In animal models, the recently licensed posaconazole (see Journal Watch Infectious Diseases Oct 4 2006) has the highest activity of the azoles. In a recent industry-sponsored, open-label study, researchers in the …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call